Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-03-12
1998-12-15
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 2, 530317, A61K 3812, C07K 754
Patent
active
058496939
ABSTRACT:
This invention relates to novel cyclic compounds linked by a heterocyclic ring system, which are useful as antagonists of the platelet glycoprotein IIb/IIIa complex, to pharmaceutical compositions containing such cyclic compounds, and to methods of using these compounds for the inhibition of platelet aggregation.
REFERENCES:
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 5041380 (1991-08-01), Ruoslahti et al.
Cadroy et al. (1989) J. Clin. Invest. 84: 939-944.
Phillips et al. (1991) Cell 65: 359-362.
Burnier et al., in Peptides, Chemistry and Biology, Proc. 12th A.P.S., Jun. 16-21, 1991.
DeGrado William Frank
Jackson Sharon Anne
Mousa Shaker Ahmed
Parthasarathy Anju
Wells Gregory James
Achutamurthy Ponnathapura
Larsen Scott K.
The DuPont Merck Pharmaceutical Company
Wessendorf T. D.
LandOfFree
Cyclic compounds linked by a heterocyclic ring useful as inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic compounds linked by a heterocyclic ring useful as inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic compounds linked by a heterocyclic ring useful as inhibit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1457889